---
title: "GlucoTrack surges 13% on Lokahi Therapeutics merger"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292802318.md"
description: "GCTK.US jumps 13% to $0.6005 on merger completion, volume hits 57.3M shares"
datetime: "2026-07-15T17:51:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292802318.md)
  - [en](https://longbridge.com/en/news/292802318.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292802318.md)
generator: "portal-rs"
---

# GlucoTrack surges 13% on Lokahi Therapeutics merger

GlucoTrack(GCTK.US) 盘中涨**13.49%**，现报**0.6005 美元**。公司已完成与 Lokahi Therapeutics 的战略合并。

成交量达**5732.98 万股**，市场交投活跃。

### Related Stocks

- [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md)

## Related News & Research

- [GlucoTrack unit Lōkahi Therapeutics expands ai² platform into three divisions](https://longbridge.com/en/news/298326260.md)
- [Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions | GCTK Stock News](https://longbridge.com/en/news/298328118.md)
- [GlucoTrack Settles Disputed Debt with Convertible Note](https://longbridge.com/en/news/298511271.md)
- [GlucoTrack issues $2 million 5% convertible note to Alto Opportunity Master Fund in settlement deal](https://longbridge.com/en/news/298504304.md)
- [GlucoTrack amends 8-K to add accountant review report for Lokahi interim financials](https://longbridge.com/en/news/297366213.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**